An Independent Blinded Review Of Suspected Drug-Induced Liver Injury (Dili) In Non-Alcoholic Steatohepatitis (Nash) Patients By A Panel Of Pathologists And Hepatologists: Lessons Learned From The Seladelpar Hepatoxicity Review Committee (Shrc)